IOPC Proceedings
27 May 2026
No Comments
INTERNATIONAL OLIGONUCLEOTIDES AND PEPTIDES CONFERENCE The IOPC is the leading event at the forefront
Archives: Articles
PEER REVIEWED – Efficient and straight forward therapeutic siRNA discovery programs in academia and early startup – a case study on rare bleeding disorders
27 May 2026
No Comments
Synthetic Oligonucleotides and the oligonucleotide Space Synthetic oligonucleotides lie at the very core of
Novel Approaches to the Manufacturing of AOCs and Oligo-Peptide Conjugates
27 May 2026
No Comments
The manufacturing of antibody–oligonucleotide conjugates (AOCs) and oligo-peptide conjugates are transforming the precision, scalability,
Patentability of Markush formulae
27 May 2026
No Comments
Introduction Within the fields of chemistry and pharmaceuticals, claims are frequently formulated to safeguard
From trial-and-error to predictive intelligence: How bespark*bio is reshaping bioprocessing
26 May 2026
No Comments
Context/Overview Breakthrough therapies often fail to reach patients. Not because biology doesn’t work, but
Industry 5.0-Ready Laboratories: Beyond Automation Towards Human-Centric, Intelligent Workflows
26 May 2026
No Comments
Introduction: From Digitalisation to Intelligence Over the past decade, many laboratories across the chemical
Science is not enough: the operational disciplines of venture capital and private equity
26 May 2026
No Comments
Introduction Biotech companies backed by venture capital or private equity face very different pressures
Linerixibat (Lynavoy)
26 May 2026
No Comments
Linerixibat is an orally administered, minimally absorbed ileal bile acid transporter (IBAT)
The data beneath the disruption: why process maturity and data accountability will determine who is ready for what comes next
26 May 2026
No Comments
Regulatory information management (RIM) has been transformed over the past decade. Most organisations by
Europe’s Critical Medicines Act: A Test of Health Sovereignty—and Industrial Resolve
26 May 2026
No Comments
For three decades, Europe has steadily shifted the production of widely used medicines—and their